2016

ViruCure Therapeutics is a biotech company that is developing an oncolytic-virus-based technology platform, NADAV, for the targeted treatment of a wide range of cancers.

Trophea AB and its subsidiary Trophea Development AB were founded in 2016. Trophea Development AB develops a topical product for the treatment of skin atrophy caused by long-term…

SwanBio Therapeutics is a gene therapy company developing leading-edge medicines to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by…

Talee Bio has two gene therapy product candidates to treat cystic fibrosis. The major hurdles of gene therapy for cystic fibrosis are poor efficacy (i.e., transduction efficiency,…

Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders.

PRUNUS Therapeutics is a preclinical stage immuno-oncology startup focusing on low-cost small molecules.

MicroQuin is a biotechnology company founded by Dr. Scott Robinson of Imperial College London and Yang Zheng of the University of Chicago. Focused on a novel and broadly impactful…

Micar Innovation is a drug discovery factory. The company has found a niche where it is able to create a large societal impact by improving the quality of life through new…

OMass is an Oxford University spin-out company applying MS technology to drug discovery.

Mogrify will develop proprietary tailored cellular conversions that power every future cell therapy